| WuXi PharmaTech (Cayman) Inc. (WuXi) is a pharmaceutical, biotechnology and medical device research and development (R&D) outsourcing company, with operations in China and the United States. The Company provides a portfolio of laboratory and manufacturing services throughout the R&D process to pharmaceutical, biotechnology and medical device companies. Its core operations are grouped into two segments: laboratory services and manufacturing. The Company's laboratory services segment consists consisting of discovery chemistry, service biology, toxicology, pharmaceutical development, analytical services, biopharmaceutical and medical device testing, and other related contract R&D services. The manufacturing segment focuses advanced intermediates, active pharmaceutical ingredients (APIs), and biologics-based manufacturing, testing and related services. During the year ended December 31, 2007, the Company provided its services to 80 pharmaceutical and biotechnology customers. |
